UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000015223
Receipt No. R000017697
Official scientific title of the study The effect of lanthanum carbonate on hyperphosphatemia in chronic kidney disease patients not on dialysis.
Date of disclosure of the study information 2014/10/01
Last modified on 2016/09/25 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of lanthanum carbonate on hyperphosphatemia in chronic kidney disease patients not on dialysis.
Title of the study (Brief title) ELAC-Hyper-CKD (Effect of LAnthanum Carbonate on Hyperphosphatemia in Chronic Kidney Disease patients)
Region
Japan

Condition
Condition non-dialysis chronic kidney disease
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the effect of lanthanum carbonate and/or existing treatment on FGF23 level in chronic kidney disease (CKD) patients not on dialysis.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase

Assessment
Primary outcomes Change from baseline and compare between 2 groups, as follow items :
FGF23, alfa-Klotho and sclerostin (at 2 months)
Key secondary outcomes Change from baseline and compare between 2 groups, as follows:
Phosphate, Calcium, Phosphate excretion in urine, iPTH, wPTH (at 2 months)
delta-FGF23, eGFR, 1/Cr, Cr, iPTH, wPTH, BAP, TRACP-5b, OPG, Mg (at 12 months)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration Institution is considered as a block.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Lanthanum carbonate
Interventions/Control_2 Existing treatment for chronic kidney disease
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients of filling the following all criteria and having ability for agreement
1) Chronic kidney disease stage G3-G4 (15 mL/min/1.73m2<=GFR<60 mL/min/1.73m2)
2) Hyperphosphatemia patients without receiving phosphate binder treatment (serum phosphate>4.5 mg/dL)
3) Available for follow-up for at least 1 year in the opinion of the investigator
Key exclusion criteria 1)<20years old
2)Malignancy of any type
3)Contraindications to lanthanum carbonate
4)Diabetes mellitus
5)Renal transplant
6)Pregnant or breast-feeding women
7)Ineligible patients for this study according to the investigator's judgment
Target sample size 140

Research contact person
Name of lead principal investigator Takashi Shigematsu
Organization Wakayama Medical University
Division name Division of Nephrology
Address 811-1, Kimiidera Wakayama city, Wakayama
TEL +81-73-441-0638
Email taki@wakatyama-med.ac.jp

Public contact
Name of contact person Masaki Ohya
Organization Wakayama Medical University
Division name Division of Nephrology
Address 811-1, Kimiidera Wakayama city, Wakayama
TEL +81-441-0639
Homepage URL
Email m-ohya@wakayama-med.ac.jp

Sponsor
Institute Wakayama Medical University
Institute
Department

Funding Source
Organization Bayer Yakuhin, Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 和歌山県立医科大学(和歌山県)

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 04 Month 15 Day
Anticipated trial start date
2014 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2016 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 09 Month 22 Day
Last modified on
2016 Year 09 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017697